JP2011525506A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525506A5
JP2011525506A5 JP2011515168A JP2011515168A JP2011525506A5 JP 2011525506 A5 JP2011525506 A5 JP 2011525506A5 JP 2011515168 A JP2011515168 A JP 2011515168A JP 2011515168 A JP2011515168 A JP 2011515168A JP 2011525506 A5 JP2011525506 A5 JP 2011525506A5
Authority
JP
Japan
Prior art keywords
formula
heart failure
disease
alkyl
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011515168A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525506A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/004390 external-priority patent/WO2009156089A1/en
Publication of JP2011525506A publication Critical patent/JP2011525506A/ja
Publication of JP2011525506A5 publication Critical patent/JP2011525506A5/ja
Withdrawn legal-status Critical Current

Links

JP2011515168A 2008-06-25 2009-06-18 心不全を処置するためのジアリールウレア類 Withdrawn JP2011525506A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08011471 2008-06-25
EP08011471.3 2008-06-25
PCT/EP2009/004390 WO2009156089A1 (en) 2008-06-25 2009-06-18 Diaryl ureas for treating heart failure

Publications (2)

Publication Number Publication Date
JP2011525506A JP2011525506A (ja) 2011-09-22
JP2011525506A5 true JP2011525506A5 (enExample) 2012-11-08

Family

ID=41136709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011515168A Withdrawn JP2011525506A (ja) 2008-06-25 2009-06-18 心不全を処置するためのジアリールウレア類

Country Status (13)

Country Link
US (1) US20110263657A1 (enExample)
EP (1) EP2293792A1 (enExample)
JP (1) JP2011525506A (enExample)
KR (1) KR20110031294A (enExample)
CN (1) CN102076338A (enExample)
AU (1) AU2009262599A1 (enExample)
BR (1) BRPI0914636A2 (enExample)
CA (1) CA2729050A1 (enExample)
IL (1) IL209647A0 (enExample)
MX (1) MX2010014441A (enExample)
RU (1) RU2011102471A (enExample)
WO (1) WO2009156089A1 (enExample)
ZA (1) ZA201009063B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102718703B (zh) * 2011-03-31 2016-09-14 中国医学科学院药物研究所 Gk和ppar双重激动活性的含有二甲基的芳基脲类衍生物
EP2723718A1 (en) 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
AP2013007331A0 (en) 2011-06-24 2013-12-31 Amgen Inc TRPM8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
RU2646454C2 (ru) * 2013-11-12 2018-03-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Способ моделирования алкогольной кардиомиопатии

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636585B2 (en) * 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl ureas with kinase inhibiting activity
PL1663978T3 (pl) * 2003-07-23 2008-04-30 Bayer Healthcare Llc Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów
WO2007087575A2 (en) * 2006-01-24 2007-08-02 University Of Chicago Compositions and methods for treating pulmonary hypertension
WO2009092442A1 (en) * 2008-01-23 2009-07-30 Universidad De Barcelona Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways

Similar Documents

Publication Publication Date Title
EP0640599B1 (en) 4-Aminopyrimidine derivatives
EP2773199B1 (en) Inhibitors of the renal outer medullary potassium channel
JP2007507551A5 (enExample)
AR069517A1 (es) Compuesto del acido fenil metiloxifenil piridinil carboxilico substituido, composiciones farmaceuticas que lo comprenden y su uso para la prepara-cion de un medicamento util para el tratamiento de una enfermedad mediada por la actividad de la enzima sgc
JPWO2003064410A1 (ja) 新規１，２，４−トリアゾール系化合物
WO2014003153A1 (ja) 置換アミド化合物
JP2006143737A5 (enExample)
JP2011507868A5 (enExample)
JP5116681B2 (ja) ２−アミノエトキシ酢酸誘導体およびそれらの使用
US9518055B2 (en) Imidazopyridyl compounds as aldosterone synthase inhibitors
EP3675858B1 (en) Imidazo[1,5-a]pyrazine compounds and compositions for ire1 inhibition
US9745282B2 (en) Indoline compounds as aldosterone synthase inhibitors
US20220411406A1 (en) Lpa receptor antagonists and uses thereof
RU2011102471A (ru) Диарилмочевины для лечения сердечной недостаточности
Sato et al. Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl-1, 2, 4-triazole derivatives as xanthine oxidoreductase inhibitors
EP3625225B1 (en) Ldha activity inhibitors
JP2008517954A (ja) 抗血小板剤としての置換ピリドキシン
WO2004000813A1 (ja) フェノキシピリジン誘導体又はその塩
US20220112217A1 (en) Pyrazolopyrimidine derivative and use thereof as pi3k inhibitor
Wang et al. Design and development of novel pyrazole-thiadiazole derivatives as NF-ĸB Inhibitor and cardioprotective effect against isoproterenol induced myocardial infarction in Sprague-Dawley rats
RU2008149917A (ru) Производные фенилпентадиеноила и их применение в качестве антагонистов par 1
JP2002255813A (ja) 蛋白修飾物生成抑制剤および方法
Zhang et al. Discovery of novel aspartate derivatives as highly potent and selective FXIa inhibitors.
US9199947B2 (en) Biaryl-propionic acid derivatives and their use as pharmaceuticals
TW200529840A (en) New pyridin-2-one compounds useful as inhibitors of thrombin